Risk Factors Associated with Children Missing the Fourth Dose of DTaP Vaccination

Zhen Zhao1

  • 1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mail Stop A19, Atlanta, GA 30333, USA.

British Journal of Medicine and Medical Research
|April 28, 2020
PubMed

Insights

Many children miss the fourth DTaP vaccine dose. Delays in previous doses, poor parent-provider relationships, and low vaccine confidence increase this risk, impacting pertussis (whooping cough) prevention.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health epidemiology

Background:

  • Pertussis (whooping cough) cases in the US surged in 2012, reaching levels not seen since 1955.
  • This highlights a critical need to understand factors affecting DTaP vaccination coverage.

Purpose of the Study:

  • To estimate the prevalence of children missing the fourth DTaP dose.
  • To identify risk factors associated with missed DTaP vaccinations, including parental vaccine confidence and provider relationships.
  • To evaluate the risk ratios for not receiving the fourth DTaP dose.

Main Methods:

  • Analysis of data from 16,919 children aged 19-35 months from the 2011 National Immunization Survey.
  • Application of weighted categorical data analysis and multivariable regression for complex sample surveys.
  • Assessment of prevalence and identification of independent risk factors for DTaP non-vaccination.

Main Results:

  • 14.7% of children missed the fourth DTaP dose.
  • Children with delayed third DTaP doses had a 2.48 times higher risk of missing the fourth dose.
  • Lower parental confidence in vaccines (RR 1.41) and poorer parent-provider relationships (62% higher risk) were significant factors.

Conclusions:

  • Timeliness of DTaP doses 1-3, provider influence, and parental vaccine confidence are key modifiable risk factors for missed fourth DTaP doses.
  • Interventions targeting improved parent-provider relationships and vaccine attitudes can enhance pertussis vaccination rates.
  • Addressing these factors is crucial for improving overall pertussis immunization coverage.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
50.9K
Probability Laws01:49

Probability Laws

Overview
43.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
652
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
745
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174